Long-Term Hibernation of Human Fetal Striatal Tissue Does Not Adversely Affect its Differentiation in Vitro or Graft Survival: Implications for Clinical Trials in Huntington's Disease

Cell Transplantation

Volumn 12, Issue 7, 2003, Pages 687-695

  Hurelbrink, Carrie B ^a   Tyers, Pam ^a   Armstrong, Richard J E ^a   Dunnett, Stephen B ^b   Barker, Roger A ^a   Rosser, Anne E ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Graft survival; Neural transplantation; Tissue storage; Xenograft

Indexed keywords

CYCLOSPORIN A; PHOSPHOPROTEIN DARPP 32; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; FETUS; FETUS (ANATOMY); GRAFT SURVIVAL; HIBERNATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; NERVE GRAFT; NERVE TRANSPLANTATION; NERVOUS TISSUE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; STRIATE CORTEX; TISSUE DIFFERENTIATION; TISSUE PRESERVATION; XENOGRAFT;

ANIMALIA;

EID: 0242407061     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000003108747307     Document Type: Article

References (49)

1. Apostolides, C.; Sanford, E.; Hong, M.; Mendez, I. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83:363-372; 1998.
2. Armstrong, R. J. E.; Harrower, T. P.; Hurelbrink, C. B.; McLaughin, M.; Ratcliffe, E. L.; Tyers, P.; Richards, A.; Dunnett, S. B.; Rosser, A. E.; Barker, R. A. Porcine neural xenografts in the immunocompetent rat: Immune response following grafting of expanded neural precursor cells. Neuroscience 106:201-216; 2001.
3. Bachoud-Lévi, A.; Bourdet, C.; Brugières, P.; Nguyen, J. P.; Grandmougin, T.; Haddad, B.; Jény, R.; Bartolomeo, P.; Boissé, M. F.; Barba, G. D.; Degos, J. D.; Ergis, A. M.; Lefaucheur, J. P.; Lisovoski, F.; Pailhous, E.; Rémy, P.; Palfi, S.; Defer, G. L.; Césaro, P.; Hantraye, P.; Peschanski, M. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp. Neurol. 161:194-202; 2000.
4. Bachoud-Lévi, A. C.; Rémy, P.; Nguyen, J. P.; Brugières, P.; Lefaucheur, J. P.; Bourdet, C.; Baudic, S.; Gaura, V.; Maison, P.; Haddad, B.; Boissé, M. F.; Grandmougin, T.; Jény, R.; Bartolomeo, P.; Dalla, B. G.; Degos, J. D.; Lisovoski, F.; Ergis, A. M.; Pailhous, E.; Césaro, P.; Hantraye, P.; Peschanski, M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356:1975-1979; 2000.
5. Barker, R. A.; Fricker, R. A.; Abrous, D. N.; Fawcett, J.; Dunnett, S. B. A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant. 4:173-200; 1995.
6. Beal, M. F.; Kowall, N. W.; Ellison, D. W.; Mazurek, M. F.; Swartz, K. J.; Martin, J. B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171; 1986.
7. Björklund, A.; Campbell, K.; Sirinathsinghji, D. J. S.; Fricker, R. A.; Dunnett, S. B. Functional capacity of striatal transplants in the rat Huntington model. In: Dunnett, S. B.; Björldund, A., eds. Functional neural transplantation. New York: Raven Press; 1994:157-195.
8. Borlongan, C. V.; Koutouzis, T. K.; Poulos, S. G.; Saporta, S.; Sanberg, P. R. Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease. Cell Transplant. 7:131-135; 1998.
9. Brundin, P.; Nilsson, O. G.; Strecker, R. E.; Lindvall, O.; Astedt, B.; Björklund, A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 65:235-240; 1986.
10. Collier, T. J.; Sladek, C. D.; Gallagher, M. J.; Blanchard, B. C.; Daley, B. F.; Foster, P. N.; Redmond, D. E.; Roth, R. H.; Sladek, J. R. Cryopreservation of fetal rat and non-human primate mesencephalic neurons: Viability in culture and neural transplantation. Prog. Brain Res. 78:631-636; 1988.
11. Department of Health. Guidance on the supply of fetal tissue for research, diagnosis and therapy. London: HMSO; 1995.
12. Dong, J. F.; Detta, A.; Hitchcock, E. R. Susceptibility of human foetal brain tissue to cool- and freeze-storage. Brain Res. 621:242-248; 1993.
13. Duan, W. M.; Widner, H.; Cameron, R. M.; Brundin, P. Quinolinic acid-induced inflammation in the stfiatum does not impair the survival of neural allografts in the rat. Eur. J. Neurosci. 10:2595-2606; 1998.
14. Evtouchenko, L.; Studer, L.; Spenger, C.; Dreher, E.; Seiler, R. W. A mathematical model for the estimation of human embryonic and fetal age. Cell Transplant. 5:453-464; 1996.
15. Freeman, T. B.; Cicchetti, F.; Hauser, R. A.; Deacon, T. W.; Li, X. J.; Hersch, S. M.; Nauert, G. M.; Sanberg, P. R.; Kordower, J. H.; Saporta, S.; Isacson, O. Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology. Proc. Natl. Acad. Sci. USA 97:13877-13882; 2000.
16. Freeman, T. B.; Hauser, R. A.; Willing, A. E.; Zigova, T.; Sanberg, P. R.; Saporta, S. Transplantation of human fetal striatal tissue in Huntington's disease: Rationale for clinical studies. Novartis Found. Symp. 231:129-138; 2000.
17. Freeman, T. B.; Kordower, J. H. Human cadaver embryonic substantia nigra grafts: Ontogeny, preoperative graft preparation and tissue storage. In: Lindvall, O.; Björklund, A.; Widner, H., eds. Intracerebral transplantation in movement disorders. Amsterdam: Elsevier Press; 1991:163-170.
18. Fricker, R. A.; Barker, R. A.; Fawcett, J. W.; Dunnett, S. B. A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant. 5:599-611; 1996.
19. Fricker, R. A.; Torres, E. M.; Hume, S. P.; Myers, R.; Opacka-Juffrey, J.; Ashworth, S.; Brooks, D. J.; Dunnett, S. B. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 79:711-721; 1997.
20. Frodl, E. M.; Sauer, H.; Lindvall, O.; Brundin, P. Effects of hibernation or cryopreservation on the survival and integration of striatal grafts placed in the ibotenate-lesioned rat caudate-putamen. Cell Transplant. 4:571-577; 1995.
21. Geny, C.; Naimi-Sadaoui, S.; Jény, R.; Belkadi, A. M.; Juliano, S. L.; Peschanski, M. Long-term delayed vascularization of human neural transplants to the rat brain. J. Neurosci. 14:7553-7562; 1994.
22. Grasbon-Frodl, E. M.; Nakao, N.; Brundin, P. The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation. Brain Res. Bull. 39:341-347; 1996.
23. Grasbon-Frodl, E. M.; Nakao, N.; Lindvall, O.; Brundin, P. Phenotypic development of the human embryonic striatal primordium: A study of cultured and grafted neurons from the lateral and medial ganglionic eminences. Neuroscience 73:171-183; 1996.
24. Hauser, R. A.; Stoessl, J. A.; Eichler, S. R.; Schwartz, S. W.; Sanberg, P. R.; Saporta, S.; Nauert, G. M.; Randall, T. S.; Hahn, M. A.; Scott, D. L.; Freeman, T. B. Pilot evaluation of human fetal striatal transplantation in Huntington's disease. Neurology 54:A153; 2000.
25. Humpel, C.; Bygdeman, M.; Olson, L.; Strömberg, I. Human fetal cortical tissue fragments survive grafting following one week storage at +4 degrees C. Cell Transplant. 3:475-479; 1994.
26. Hurelbrink, C. B.; Armstrong, R. J.; Barker, R. A.; Dunnett, S. B.; Rosser, A. E. Hibernated human fetal striatal tissue: Successful transplantation in a rat model of Huntington's disease. Cell Transplant. 9:743-749; 2000.
27. Hurelbrink, C. B.; Armstrong, R. J. E.; Dunnett, S. B.; Rosser, A. E.; Barker, R. A. Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS. Eur. J. Neurosci. 15:1255-1266; 2002.
28. Kawamoto, J. C.; Barrett, J. N. Cryopreservation of primary neurons for tissue culture. Brain Res. 384:84-93; 1986.
29. Kendall, A. L.; Rayment, F. D.; Torres, E. M.; Baker, H. F.; Ridley, R. M.; Dunnett, S. B. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat. Med. 4:727-729; 1998.
30. Koelle, G. B. The histochemical identification of acetylcholinesterase in cholinergic, adrenergic and sensory organs. J. Pharmacol. Exp. Ther. 114: 167; 1955.
31. Kopyov, O. V.; Jacques, S.; Lieberman, A.; Duma, C. M.; Eagle, K. S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 149:97-108; 1998.
32. Kordower, J. H.; Freeman, T. B.; Snow, B. J.; Vingerhoets, F. J.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Smith, D. A.; Nauert, G. M.; Perl, D. P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124; 1995.
33. Lindvall, O.; Hagell, P. Clinical observations after neural transplantation in Parkinson's disease. Prog. Brain Res. 127:299-320; 2000.
34. Mendez, I.; Dagher, A.; Hong, M.; Hebb, A.; Gaudet, P.; Law, A.; Weerasinghe, S.; King, D.; Desrosiers, J.; Darvesh, S.; Acorn, T.; Robertson, H. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations. J. Neurosurg. 92:863-869; 2000.
35. Naimi, S.; Jény, R.; Hantraye, P.; Peschanski, M.; Riche, D. Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain. Exp. Neurol. 137:15-25; 1996.
36. Nikkhah, G.; Eberhard, J.; Olsson, M.; Björklund, A. Preservation of fetal ventral mesencephalic cells by cool storage: In-vitro viability and TH-positive neuron survival after microtransplantation to the striatum. Brain Res. 687:22-34; 1995.
37. Philpott, L. M.; Kopyov, O. V.; Lee, A. J.; Jacques, S.; Duma, C. M.; Caine, S.; Yang, M.; Eagle, K. S. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: Three case presentations. Cell Transplant. 6:203-212; 1997.
38. Polkinghorne, J. Review of the guidance on the research use of fetuses and fetal material. London: HMSO; 1989.
39. Pundt, L. L.; Kondoh, T.; Conrad, J. A.; Low, W. C. Transplantation of human striatal tissue into a rodent model of Huntington's disease: Phenotypic expression of transplanted neurons and host-to-graft innervation. Brain Res. Bull. 39:23-32; 1996.
40. Rosser, A. E.; Barker, R. A.; Guillard, J.; Harrower, T. P.; Watts, C.; Pickard, J.; Dunnett, S. B.; the NEST-UK consortium. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report. J. Neurol. Neurosurg. Psychiatry 73:678-685; 2002.
41. Sauer, H. Pregraft tissue storage methods for intracerebral transplantation. In: Dunnett, S. B.; Boulton, A. A.; Baker, G. B., eds. Neural transplantation methods. Totowa, NJ: Humana Press Inc.; 2000:27-40.
42. Sauer, H.; Brundin, P. Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor. Neurol. Neurosci. 2:123-135; 1991.
43. Sauer, H.; Frodl, E. M.; Kupsch, A.; ten Bruggencate, G.; Oertel, W. H. Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease. Exp. Brain Res. 90:54-62; 1992.
44. Spencer, D. D.; Robbins, R. J.; Naftolin, F.; Marek, K. L.; Vollmer, T.; Leranth, C.; Roth, R. H.; Price, L. H.; Gjedde, A.; Bunney, B. S. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327:1541-1548; 1992.
45. Thajeb, P.; Ling, Z. D.; Potter, E. D.; Carvey, P. M. The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells. Cell Transplant. 6:297-307; 1997.
46. Thian, S.; Watts, C.; Torres, E. M.; Everitt, B. J.; Blakemore, W. F.; Dunnett, S. B. The effect of interval between lesion and transplantation on striatal graft survival and integration in the quinolinic acid lesioned neostriatum of rats. Soc. Neurosci. Absr. 22; 1996.
47. Watts, C.; Caldwell, M. A.; Dunnett, S. B. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplant. 7:573-583; 1998.
48. Watts, C.; Dunnett, S. B. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: Implications for timing of surgical intervention. J. Neurosurg. 89:267-274; 1998.
49. Widner, H. The Lund transplant program for Parkinson's disease and patients with MPTP-induced parkinsonism. In: Freeman, T. B.; Widner, H., eds. Cell transplantation for neurological disorders: Toward reconstruction of the human central nervous system. Totowa, NJ: Humana Press; 1998:1-17.